Insmed Inc. buy JPMorgan Chase & Co.
Start price
20.06.24
/
50%
€62.50
Target price
20.06.25
€67.14
Performance (%)
5.60%
Price
16.09.24
€64.50
Summary
This prediction is currently active. With a performance of 5.60%, the BUY prediction by JPMorgan_Chase___Co_ for Insmed Inc. is trending in the right direction. This prediction currently runs until 20.06.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Insmed Inc. | -0.769% | -0.769% |
iShares Core DAX® | 1.195% | 2.111% |
iShares Nasdaq 100 | 3.220% | -1.375% |
iShares Nikkei 225® | 1.858% | 0.888% |
iShares S&P 500 | 2.168% | 0.612% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at JPMorgan Chase & Co. from $55.00 to $72.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat